Cargando…

Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study

BACKGROUND: Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramakrishnan, Arulraj, Velmurugan, Ganesan, Somasundaram, Aravindh, Mohanraj, Sundaresan, Vasudevan, Dinakaran, Vijayaragavan, Paari, Nightingale, Peter, Swaminathan, Krishnan, Neuberger, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289630/
https://www.ncbi.nlm.nih.gov/pubmed/35860452
http://dx.doi.org/10.1016/j.eclinm.2022.101553
_version_ 1784748711395459072
author Ramakrishnan, Arulraj
Velmurugan, Ganesan
Somasundaram, Aravindh
Mohanraj, Sundaresan
Vasudevan, Dinakaran
Vijayaragavan, Paari
Nightingale, Peter
Swaminathan, Krishnan
Neuberger, James
author_facet Ramakrishnan, Arulraj
Velmurugan, Ganesan
Somasundaram, Aravindh
Mohanraj, Sundaresan
Vasudevan, Dinakaran
Vijayaragavan, Paari
Nightingale, Peter
Swaminathan, Krishnan
Neuberger, James
author_sort Ramakrishnan, Arulraj
collection PubMed
description BACKGROUND: Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there are few data in physically active rural populations without attributable metabolic risk factors. This aim of this study is to investigate the prevalence of abnormal liver functions tests (LFTs) and liver fibrosis among adults in a rural population. METHODS: This cross-sectional study included observations from KMCH-NNCD-II (2017) study (n = 907) from a farming village, Nallampatti, located in South India. We assessed lifestyle (occupation, tobacco use and alcohol consumption using AUDIT-C questionnaire), markers for metabolic diseases (obesity, hypertension, diabetes, hypercholesterolemia), LFTs and markers for hepatitis viruses B and C. 901 participants had transient elastography to assess fibrosis. Participants with abnormal LFTs and significant liver fibrosis (F2-F4) underwent additional liver screening (caeruloplasmin, iron studies and autoimmune hepatitis panel). Multiple logistic regression analyses were performed to understand the association of liver fibrosis with lifestyle and metabolic risk factors after adjustment for co-variates. FINDINGS: Significant liver fibrosis (F2-F4) was observed in 14.4%, and cirrhosis in 0.8%. There was an association of liver fibrosis with abnormal LFTs but no association between alcohol consumption, viral hepatitis, hepatic liver screening and liver fibrosis. Among metabolic risk factors, no association was observed for hypertension and hypercholesterolemia but diabetes [OR – 3.206 (95% CI: 1.792 – 5.736)], obesity [1.987 (1.341 – 2.944)] and metabolic syndrome [2.539 (1.680 – 3.836)] showed association with significant liver fibrosis (F2-F4) after adjustment for confounding factors. INTERPRETATION: Our results suggest that the prevalence of liver fibrosis in rural population is similar to urban counterparts. The association of metabolic risk factors with liver fibrosis in physically active rural population warrants further investigations in future studies. FUNDING: This study is funded by KMCH Research Foundation, India.
format Online
Article
Text
id pubmed-9289630
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92896302022-07-19 Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study Ramakrishnan, Arulraj Velmurugan, Ganesan Somasundaram, Aravindh Mohanraj, Sundaresan Vasudevan, Dinakaran Vijayaragavan, Paari Nightingale, Peter Swaminathan, Krishnan Neuberger, James eClinicalMedicine Articles BACKGROUND: Liver disease is the only major chronic disease and mortality is increasing. Earlier detection of liver fibrosis can reduce progression to cirrhosis and hepatocellular carcinoma. Many studies have reported an increased prevalence in liver fibrosis among adults in urban regions but there are few data in physically active rural populations without attributable metabolic risk factors. This aim of this study is to investigate the prevalence of abnormal liver functions tests (LFTs) and liver fibrosis among adults in a rural population. METHODS: This cross-sectional study included observations from KMCH-NNCD-II (2017) study (n = 907) from a farming village, Nallampatti, located in South India. We assessed lifestyle (occupation, tobacco use and alcohol consumption using AUDIT-C questionnaire), markers for metabolic diseases (obesity, hypertension, diabetes, hypercholesterolemia), LFTs and markers for hepatitis viruses B and C. 901 participants had transient elastography to assess fibrosis. Participants with abnormal LFTs and significant liver fibrosis (F2-F4) underwent additional liver screening (caeruloplasmin, iron studies and autoimmune hepatitis panel). Multiple logistic regression analyses were performed to understand the association of liver fibrosis with lifestyle and metabolic risk factors after adjustment for co-variates. FINDINGS: Significant liver fibrosis (F2-F4) was observed in 14.4%, and cirrhosis in 0.8%. There was an association of liver fibrosis with abnormal LFTs but no association between alcohol consumption, viral hepatitis, hepatic liver screening and liver fibrosis. Among metabolic risk factors, no association was observed for hypertension and hypercholesterolemia but diabetes [OR – 3.206 (95% CI: 1.792 – 5.736)], obesity [1.987 (1.341 – 2.944)] and metabolic syndrome [2.539 (1.680 – 3.836)] showed association with significant liver fibrosis (F2-F4) after adjustment for confounding factors. INTERPRETATION: Our results suggest that the prevalence of liver fibrosis in rural population is similar to urban counterparts. The association of metabolic risk factors with liver fibrosis in physically active rural population warrants further investigations in future studies. FUNDING: This study is funded by KMCH Research Foundation, India. Elsevier 2022-07-14 /pmc/articles/PMC9289630/ /pubmed/35860452 http://dx.doi.org/10.1016/j.eclinm.2022.101553 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Ramakrishnan, Arulraj
Velmurugan, Ganesan
Somasundaram, Aravindh
Mohanraj, Sundaresan
Vasudevan, Dinakaran
Vijayaragavan, Paari
Nightingale, Peter
Swaminathan, Krishnan
Neuberger, James
Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title_full Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title_fullStr Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title_full_unstemmed Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title_short Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: A cross-sectional study
title_sort prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: a cross-sectional study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289630/
https://www.ncbi.nlm.nih.gov/pubmed/35860452
http://dx.doi.org/10.1016/j.eclinm.2022.101553
work_keys_str_mv AT ramakrishnanarulraj prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT velmuruganganesan prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT somasundaramaravindh prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT mohanrajsundaresan prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT vasudevandinakaran prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT vijayaragavanpaari prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT nightingalepeter prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT swaminathankrishnan prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy
AT neubergerjames prevalenceofabnormallivertestsandliverfibrosisamongruraladultsinlowandmiddleincomecountryacrosssectionalstudy